Z
Zhongwei Sun
Researcher at Peking Union Medical College
Publications - 15
Citations - 584
Zhongwei Sun is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 6, co-authored 12 publications receiving 384 citations.
Papers
More filters
Journal ArticleDOI
Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis
Bo Xu,Shengxian Tu,Shubin Qiao,Xinkai Qu,Yundai Chen,Junqing Yang,Lijun Guo,Zhongwei Sun,Zehang Li,Feng Tian,Wei-Yi Fang,Jiyan Chen,Wei Li,Changdong Guan,Niels Ramsing Holm,William Wijns,Shengshou Hu +16 more
TL;DR: The study met its prespecified primary performance goal for the level of diagnostic accuracy of QFR in identifying hemodynamically significant coronary stenosis.
Journal ArticleDOI
In vivo comparison of arterial lumen dimensions assessed by co-registered three-dimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography
Shengxian Tu,Liang Xu,Jurgen Ligthart,Bo Xu,Karen Witberg,Zhongwei Sun,Gerhard Koning,Johan H. C. Reiber,Evelyn Regar +8 more
TL;DR: A comparison of co-registered 3D QCA and invasive imaging data suggests a bias towards larger lumen dimensions by IVUS and by OCT, which was more pronounced in larger and tortuous vessels.
Journal ArticleDOI
Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
Yu Tan,Zhaoxue Sheng,Peng Zhou,Chen Liu,Hanjun Zhao,Li Song,Jiannan Li,Jinying Zhou,Yi Chen,Laiyuan Wang,Hai-Yan Qian,Zhongwei Sun,Shubin Qiao,Bo Xu,Runlin Gao,Hongbing Yan +15 more
TL;DR: High levels of plasma TMAO independently correlated with plaque rupture in patients with ST-segment–elevation myocardial infarction and might be a useful biomarker for plaque rupture to improve risk stratification and management.
Journal ArticleDOI
Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial.
Lei Song,Shengxian Tu,Zhongwei Sun,Yang Wang,Daixin Ding,Changdong Guan,Lihua Xie,Javier Escaned,William F. Fearon,Ajay J. Kirtane,Patrick W. Serruys,William Wijns,Stephan Windecker,Martin B. Leon,Gregg W. Stone,Shubin Qiao,Bo Xu +16 more
TL;DR: The FAVOR III China study will be the first randomized trial to examine the effectiveness and cost-effectiveness of a QFR-guided versus an angiography-guided PCI strategy in coronary artery disease patients.
Journal ArticleDOI
Association of Acute Procedural Results With Long-Term Outcomes After CTO PCI.
Changdong Guan,Weixian Yang,Lei Song,Jue Chen,Jie Qian,Fan Wu,Tongqiang Zou,Yanpu Shi,Zhongwei Sun,Lihua Xie,Lijian Gao,Jingang Cui,Jie Zhao,Ajay J. Kirtane,Robert W. Yeh,Yongjian Wu,Yuejin Yang,Shubin Qiao,Emmanouil S. Brilakis,Bo Xu +19 more
TL;DR: In this large cohort of CTO PCI patients, suboptimal recanalization was associated with significantly higher long-term incidence of cardiac death and MI compared with optimal recanAlization or procedural failure.